(Q35030805)

5 August 2017

1 reference

title

Therapeutic points of intervention and clinical implications: role of desloratadine (English)

1 reference

5 August 2017

C Bachert

1

1 reference

5 August 2017

language of work or name

1 reference

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

57 Suppl 75

1 reference

5 August 2017

page(s)

13-18

1 reference

Allergic rhinitis and its impact on asthma

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Desloratadine: A new, nonsedating, oral antihistamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Cross-reactivity between Platanus pollen and vegetables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Features and severity of occupational asthma upon diagnosis: an Italian multicentric case review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Olive allergen-specific IgE responses in patients with Olea europaea pollinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

7 January 2021

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

7 January 2021

Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

7 January 2021

Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM‐1 and HLA‐DR by nasal epithelial cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.3.X

7 January 2021

10.1034/J.1398-9995.57.S75.3.X

Identifiers

DOI

1 reference

5 August 2017

1 reference